AU2003303949A8 - Treatments for leishmaniasis - Google Patents

Treatments for leishmaniasis

Info

Publication number
AU2003303949A8
AU2003303949A8 AU2003303949A AU2003303949A AU2003303949A8 AU 2003303949 A8 AU2003303949 A8 AU 2003303949A8 AU 2003303949 A AU2003303949 A AU 2003303949A AU 2003303949 A AU2003303949 A AU 2003303949A AU 2003303949 A8 AU2003303949 A8 AU 2003303949A8
Authority
AU
Australia
Prior art keywords
leishmaniasis
treatments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003303949A
Other versions
AU2003303949A1 (en
Inventor
Luz I Romero
Todd Capson
Luis Cubilla Rios
Eduardo Ortega-Barria
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smithsonian Tropical Research Institute
Original Assignee
Smithsonian Tropical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithsonian Tropical Research Institute filed Critical Smithsonian Tropical Research Institute
Publication of AU2003303949A1 publication Critical patent/AU2003303949A1/en
Publication of AU2003303949A8 publication Critical patent/AU2003303949A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003303949A 2002-09-04 2003-09-04 Treatments for leishmaniasis Abandoned AU2003303949A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40771402P 2002-09-04 2002-09-04
US60/407,714 2002-09-04
PCT/US2003/027469 WO2004084801A2 (en) 2002-09-04 2003-09-04 Treatments for leishmaniasis

Publications (2)

Publication Number Publication Date
AU2003303949A1 AU2003303949A1 (en) 2004-10-18
AU2003303949A8 true AU2003303949A8 (en) 2004-10-18

Family

ID=33097605

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003303949A Abandoned AU2003303949A1 (en) 2002-09-04 2003-09-04 Treatments for leishmaniasis

Country Status (2)

Country Link
AU (1) AU2003303949A1 (en)
WO (1) WO2004084801A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188065B2 (en) 2008-10-02 2012-05-29 Osteogenex Inc. Boldine compounds for promoting bone growth
ES2402253B1 (en) * 2011-09-30 2014-03-04 Universidade De Santiago De Compostela USE OF OXOISOAPORFINS IN THE TREATMENT AGAINST LEISHMANIOSIS.
CN106810926B (en) * 2017-01-11 2019-01-29 云南民族大学 A kind of application of aporphine alkaloid
PL434649A1 (en) * 2020-07-13 2022-01-17 Adifeed Spółka Z Ograniczoną Odpowiedzialnością Veterinary composition for treatment and/or prevention of diseases caused by protozoa of the Apikompleksa type (Apicomplexa) in animals, containing as an active ingredient glaucine or extract of the herb Siwiec (Glaucium sp.) and method of its production
CN113004201B (en) * 2021-03-05 2022-08-05 中国药科大学 Aporphine alkaloid derivative and preparation method and medical application thereof
CN112999225B (en) * 2021-03-05 2023-02-17 中国药科大学 Medical application of aporphine alkaloid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262421A (en) * 1991-12-02 1993-11-16 National Science Council Use of dicentrine and its derivatives for the treatment of hypertension, arrhythmia, thrombosis and atherosclerosis

Also Published As

Publication number Publication date
WO2004084801A2 (en) 2004-10-07
AU2003303949A1 (en) 2004-10-18
WO2004084801A3 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
GB2392460B (en) Delayed-gelation solution
EP1558585A4 (en) Neurologically-active compounds
EP1516634A4 (en) Volatilizer
GB0200283D0 (en) Compounds
PL397821A1 (en) 1-acetyl-6-fluoro-2-indolinone compound
GB0204775D0 (en) Component access
GB0204241D0 (en) Compound
AU2003216859A8 (en) Amidoacetonitrile compounds
GB0221574D0 (en) Treatments
AU2003290818A8 (en) Topoisomerase-targeting agents
AU2003303949A8 (en) Treatments for leishmaniasis
GB0224830D0 (en) Compound
GB0203778D0 (en) Compounds
GB0213027D0 (en) Compound
AU2003275480A8 (en) Compounds
GB0213461D0 (en) Baths
AU2003295393A8 (en) Ghb treatment methods
EP1463794A4 (en) Immidazoline quats
GB0204798D0 (en) Cycostatic agents
GB0213493D0 (en) Treatment
GB0220820D0 (en) Treatment
HU0200077V0 (en) Bathing-drawers for babyes
GB0220818D0 (en) Services-connections for trailer-vehicles
HK1039722A2 (en) Advanced calculation
PL353382A1 (en) Set for teleshooting

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase